
USD $195.72
Lenvatol (Lenvatinib) is a targeted therapy used primarily for the treatment of certain types of cancer, including thyroid cancer and renal cell carcinoma. It works by inhibiting specific pathways that promote cancer cell growth and survival.
Lenvatol is indicated for the treatment of:
Lenvatol inhibits multiple receptor tyrosine kinases, which are involved in the proliferation and survival of cancer cells. By blocking these pathways, it helps to slow or stop the growth of tumors.
The recommended starting dose of Lenvatol is determined based on the specific cancer type and patient characteristics. It's important to follow your healthcare provider’s instructions regarding dosage and administration.
Common side effects of Lenvatol may include:
Before starting Lenvatol, inform your healthcare provider about any pre-existing conditions, especially:
The duration of treatment varies depending on individual response and the type of cancer being treated. Consult your healthcare provider for personalized guidance.
Always inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.
If you miss a dose, take it as soon as you remember. If it’s almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not double up on doses.
Lenvatol (Lenvatinib) is a vital treatment option for various cancers, offering targeted therapy to improve patient outcomes. Always consult with your healthcare provider for more information and personalized treatment plans.